DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR FLUORODOPA F-18

« Back to Dashboard

All Clinical Trials for Fluorodopa F-18

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00674440	Utility of [F-18] fluoroDOPA for Neonatal Hyperinsulinism	Active, not recruiting	University of Pennsylvania	Phase 2	2004-12-01	Children with congenital hyperinsulinism (CHI) have low blood sugar, and some of these children may require surgery. In this study, researchers affiliated with the University of Pennsylvania will test how well a radioactive drug (called F-DOPA) can detect a form of hyperinsulinism that may be cured by surgery. Eligible participants in this study will have positron emission tomography (PET) scans with F-DOPA prior to surgery.
NCT00674440	Utility of [F-18] fluoroDOPA for Neonatal Hyperinsulinism	Active, not recruiting	Children's Hospital of Philadelphia	Phase 2	2004-12-01	Children with congenital hyperinsulinism (CHI) have low blood sugar, and some of these children may require surgery. In this study, researchers affiliated with the University of Pennsylvania will test how well a radioactive drug (called F-DOPA) can detect a form of hyperinsulinism that may be cured by surgery. Eligible participants in this study will have positron emission tomography (PET) scans with F-DOPA prior to surgery.
NCT01165632	Fluorine F 18 Fluorodopa-Labeled PET Scan in Planning Surgery and Radiation Therapy in Treating Patients With Newly Diagnosed High- or Low-Grade Malignant Glioma	Active, not recruiting	National Cancer Institute (NCI)	N/A	2010-07-01	RATIONALE: New imaging procedures, such as fluorine F 18 fluorodopa-labeled PET scan, may help in guiding surgery and radiation therapy and allow doctors to plan better treatment. PURPOSE: This clinical trial studies fluorine F 18 fluorodopa-labeled PET scan in planning surgery and radiation therapy in treating patients with newly diagnosed high- or low-grade malignant glioma

Clinical Trial Conditions for Fluorodopa F-18

Condition Name

Condition Name for Fluorodopa F-18
Intervention	Trials
Malignant Glioma	4
Adult Oligodendroglioma	2
Adult Diffuse Astrocytoma	2

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Fluorodopa F-18
Intervention	Trials
Glioma	7
Glioblastoma	4
Congenital Hyperinsulinism	2

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Fluorodopa F-18

Trials by Country

Trials by Country for Fluorodopa F-18
Location	Trials
United States	11

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Fluorodopa F-18
Location	Trials
Minnesota	4
Texas	2
Pennsylvania	2
California	1
Arizona	1

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Fluorodopa F-18

Clinical Trial Phase

Clinical Trial Phase for Fluorodopa F-18
Clinical Trial Phase	Trials
Phase 2	4
Phase 1/Phase 2	1
Phase 1	2

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Fluorodopa F-18
Clinical Trial Phase	Trials
Terminated	3
Active, not recruiting	3
Recruiting	3

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Fluorodopa F-18

Sponsor Name

Sponsor Name for Fluorodopa F-18
Sponsor	Trials
National Cancer Institute (NCI)	5
Mayo Clinic	4
The Methodist Hospital System	1

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Fluorodopa F-18
Sponsor	Trials
Other	12
NIH	5

Export unavailable in trial.
Subscribe for complete access.